Recent Investment Analysts’ Ratings Changes for Macerich (MAC)

A number of research firms have changed their ratings and price targets for Macerich (NYSE: MAC):

• 3/10/2025 – Macerich had its price target lowered by analysts at JPMorgan Chase & Co. from $22.00 to $18.00. They now have an “underweight” rating on the stock.
• 3/10/2025 – Macerich had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.70 to $14.40. They now have a “sell” rating on the stock.
• 3/6/2025 – Macerich had its price target lowered by analysts at Scotiabank from $22.00 to $21.00. They now have a “sector perform” rating on the stock.
• 2/28/2025 – Macerich had its price target lowered by analysts at Piper Sandler from $17.00 to $16.00. They now have an “underweight” rating on the stock.

Macerich Stock Up 1.6 %

Shares of NYSE MAC opened at $16.47 on Monday. The Macerich Company has a 52 week low of $12.99 and a 52 week high of $22.27. The business has a 50-day simple moving average of $19.54 and a two-hundred day simple moving average of $19.08. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 1.68. The company has a market cap of $4.16 billion, a P/E ratio of 42.22, a P/E/G ratio of 0.71 and a beta of 2.62.

Macerich Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, March 4th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 4.13%. Macerich’s dividend payout ratio is -86.08%.

Insiders Place Their Bets

In other news, Director Andrea M. Stephen sold 63,289 shares of the business’s stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $20.59, for a total transaction of $1,303,120.51. Following the transaction, the director now directly owns 83,479 shares of the company’s stock, valued at approximately $1,718,832.61. The trade was a 43.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.53% of the company’s stock.

Institutional Investors Weigh In On Macerich

Several hedge funds have recently made changes to their positions in MAC. Janney Montgomery Scott LLC boosted its position in shares of Macerich by 26.3% during the third quarter. Janney Montgomery Scott LLC now owns 47,804 shares of the real estate investment trust’s stock valued at $872,000 after purchasing an additional 9,943 shares in the last quarter. Assetmark Inc. boosted its position in shares of Macerich by 5.6% during the third quarter. Assetmark Inc. now owns 18,404 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 971 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Macerich by 7.7% during the third quarter. Victory Capital Management Inc. now owns 89,058 shares of the real estate investment trust’s stock valued at $1,624,000 after purchasing an additional 6,346 shares in the last quarter. Metis Global Partners LLC boosted its position in shares of Macerich by 31.1% during the third quarter. Metis Global Partners LLC now owns 22,242 shares of the real estate investment trust’s stock valued at $406,000 after purchasing an additional 5,280 shares in the last quarter. Finally, Quest Partners LLC boosted its position in shares of Macerich by 851.9% during the third quarter. Quest Partners LLC now owns 30,529 shares of the real estate investment trust’s stock valued at $557,000 after purchasing an additional 27,322 shares in the last quarter. 87.38% of the stock is currently owned by institutional investors.

Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.